Your session is about to expire
← Back to Search
Laser Therapy
Thulium Laser for Kidney Stones (HOTLaser Trial)
N/A
Waitlist Available
Led By David W Sobel, MD
Research Sponsored by MaineHealth
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Stone burden (multiple stones acceptable) with largest stone 1cm - 3 cm in greatest dimension on bone window of noncontrast CT within a 6 month preoperative period
Age 21 or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up the duration of the procedure
Awards & highlights
HOTLaser Trial Summary
"This trial is comparing two types of lasers, one from Boston Scientific and one from Olympus, to see which one is better for treating medium-to-large kidney stones using a minimally invasive procedure."
Who is the study for?
This trial is for individuals with medium-to-large kidney stones who are candidates for a minimally invasive surgical procedure called mini PCNL. Specific eligibility details aren't provided, but typically participants should be in stable health and meet certain criteria set by the surgeon.Check my eligibility
What is being tested?
The study compares two types of lasers used in kidney stone surgery: the Boston Scientific Lumenis Pulse 120H Moses 2.0 holmium laser and the Olympus Soltive Superpulsed thulium fiber laser (TFL). Patients will be randomly assigned to one of these treatments.See study design
What are the potential side effects?
While specific side effects are not listed, typical risks associated with laser kidney stone treatment include bleeding, infection, pain during or after surgery, potential damage to surrounding tissues, and possible need for additional procedures.
HOTLaser Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have kidney stones, with the largest being between 1cm and 3cm.
Select...
I am 21 years old or older.
Select...
I am scheduled for a mini surgery to remove kidney stones.
HOTLaser Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ the duration of the operation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~the duration of the operation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Laser Treatment Time
Secondary outcome measures
Retreatment rate
Stone-Free Rate
Total Operative Time
Other outcome measures
Length of stay
Safety Profile and Adverse Events
Subjective pain scores
HOTLaser Trial Design
2Treatment groups
Active Control
Group I: Thulium LaserActive Control1 Intervention
Participants in this arm are randomized to be treated using the Olympus Soltive SuperPulsed Thulium Fiber Laser
Group II: Holmium LaserActive Control1 Intervention
Participants in this arm are randomized to be treated using the Lumenis Pulse 120H Moses 2.0 Holmium Laser
Find a Location
Who is running the clinical trial?
MaineHealthLead Sponsor
72 Previous Clinical Trials
49,475 Total Patients Enrolled
Boston Scientific CorporationIndustry Sponsor
720 Previous Clinical Trials
932,970 Total Patients Enrolled
3 Trials studying Kidney Stones
60 Patients Enrolled for Kidney Stones
David W Sobel, MDPrincipal InvestigatorMaineHealth
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the recruitment for this medical study limited to individuals who have reached 18 years of age or older?
"Recruitment for this study targets individuals over 21 years of age but under the age of 90."
Answered by AI
Are there any available slots for patients to participate in this research study?
"According to details on clinicaltrials.gov, recruitment for this research project is currently closed. The trial was initially listed on 3/1/2024 and last modified on 2/11/2024. While this specific study is not enrolling participants at the moment, it's worth noting that there are currently 82 other active trials looking for eligible candidates."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger